Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Prometheus Biosciences, Inc. Common Stock Graphic](https://lunarcrush.com/gi/w:26/t:$rxdx.png) Prometheus Biosciences, Inc. Common Stock (RXDX)

RXDX stock is buzzing with acquisition talks, with positive sentiment driving engagement. The stock price remains stable at $XXXXXX.

### About Prometheus Biosciences, Inc. Common Stock
Prometheus Biosciences, Inc. Common Stock (RXDX) is a healthcare sector stock.  
Prometheus Biosciences, Inc. Common Stock uses the ticker $RXDX for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$rxdx/insights)
- Prometheus Biosciences, Inc. Common Stock (RXDX) market dominance near a 52-week low at XXXXX.
- Prometheus Biosciences, Inc. Common Stock (RXDX) galaxy score™ is up XX% from the previous month.
- Prometheus Biosciences, Inc. Common Stock (RXDX) creators is up XXXXX% from the previous month.
- Prometheus Biosciences, Inc. Common Stock (RXDX) engagements is up XXXXXX% from the previous week.

### Price: $XXXXXX [#](/topic/$rxdx/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$rxdx/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/$rxdx/time-series/close.tsv)  
The stock price of $XXXXXX is likely supported by positive social sentiment regarding acquisition potential, despite the lack of recent price movement and being near its 52-week low.  

**1-Year High**: $XXXXXX on 2024-07-21  
**1-Year Low**: $XXXXXX on 2024-07-21  
  
  
### AltRank: XXXXX [#](/topic/$rxdx/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$rxdx/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/$rxdx/time-series/alt_rank.tsv)  
Prometheus Biosciences, Inc. Common Stock (RXDX) is currently AltRank #1,085 based on combined combined social and market metrics
**Daily Average**: XXXXX  
**1 Week**: XXXXX -XX  
**1 Month**: XXXXX -XXX  
**6 Months**: XXXXX +917  
**1 Year**: XXXXX +42  
**1-Year High**: XXXXX on 2025-06-26  
**1-Year Low**: XX on 2024-12-07  
  
  
### Galaxy Score: XXXXX [#](/topic/$rxdx/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$rxdx/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/$rxdx/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +12  
**1 Month**: XX +16  
**6 Months**: XX -XX  
**1 Year**: XX -XX  
**1-Year High**: XX on 2025-03-03  
**1-Year Low**: XX on 2025-05-24  
  
  
### Engagements: XXX [#](/topic/$rxdx/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$rxdx/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$rxdx/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXXX +137%  
**1 Month**: XXXXXX -XX%  
**6 Months**: XXXXXXX -XX%  
**1 Year**: XXXXXXX -XX%  
**1-Year High**: XXXXXX on 2024-08-20  
**1-Year Low**: X on 2024-09-02  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: XX [#](/topic/$rxdx/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$rxdx/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$rxdx/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Week**: XX no change  
**1 Month**: XX +35%  
**6 Months**: XXX -XX%  
**1 Year**: XXX -XX%  
**1-Year High**: XXX on 2024-11-24  
**1-Year Low**: X on 2025-05-10  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: XX [#](/topic/$rxdx/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$rxdx/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$rxdx/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Prometheus Biosciences, Inc. Common Stock (RXDX) in the last XX hours which is up XX% from XX in the previous XX hours
**Daily Average**: X  
**1 Week**: XX +13%  
**1 Month**: XX +76%  
**6 Months**: XX -XX%  
**1 Year**: XXX +3.70%  
**1-Year High**: XX on 2024-10-22  
**1-Year Low**: X on 2025-05-10  

The most influential creators that mention Prometheus Biosciences, Inc. Common Stock in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@Quantumup1](/creator/twitter/Quantumup1) | X    | XXXXX     | X     | XXXXX       |

[View More](/list/creators/$rxdx/100)
  
  
### Sentiment: XXX% [#](/topic/$rxdx/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$rxdx/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$rxdx/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% +50%  
**6 Months**: XXX% no change  
**1 Year**: XXX% no change  
**1-Year High**: XXX% on 2024-07-22  
**1-Year Low**: XX% on 2025-02-12  

**Most Supportive Themes**
- **Acquisition Potential:** (80%) The strategic value of RXDX and other biotech stocks is highlighted, indicating positive sentiment towards potential acquisitions and growth.
  
**Most Critical Themes**
- **Overpayment Concerns:** (20%)  Concerns about overpayment for RXDX in acquisitions.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %  |
| ------- | -------- | -  | ------- | -   | -------- | -  |
| X       | XX       | X% | XXX     | XX% | X        | X% |
|         |          |    |         |     |          |    |
| Total   | XX       | X% | XXX     | XX% | X        | X% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/$rxdx/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rxdx/c:line/m:social_dominance.svg)  
[Social Dominance 24-Hour Chart Data](/topic/$rxdx/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXXXX%  
**1 Week**: XXXXXXX% -XXXXXXXXXXXXXXXXXXXXX%  
**1 Month**: XXXXX% +0.0075%  
**6 Months**: XXXXX% +0.0083%  
**1 Year**: XXXXX% +0.0088%  
**1-Year High**: XXXXX% on 2024-11-24  
**1-Year Low**: XXXXXX% on 2025-05-10  
  
  
### Market Dominance: XXXXX% [#](/topic/$rxdx/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rxdx/c:line/m:market_dominance.svg)  
[Market Dominance 24-Hour Chart Data](/topic/$rxdx/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-05-19  
**1-Year Low**: XXXXX% on 2025-07-17  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$rxdx/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$rxdx/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/$rxdx/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Month**: $XXXXXXXXXXXXX no change  
**1-Year High**: $XXXXXXXXXXXXX on 2025-05-18  
**1-Year Low**: $XXXXXXXXXXXXX on 2025-05-18  

**Top assets mentioned**
In the posts about Prometheus Biosciences, Inc. Common Stock in the last XX hours

[Eli Lilly and Company (LLY)](/topic/$lly)
[Cere Network (CERE)](/topic/$cere)
[Catalent Inc (CTLT)](/topic/$ctlt)
[Bull Market (BULL)](/topic/$bull)
[Johnson & Johnson (JNJ)](/topic/$jnj)
[Bitcoin Incognito (XBI)](/topic/$xbi)
[Intra-Cellular Therapies Inc. (ITCI)](/topic/$itci)
[Blueprint Medicines Corporation (BPMC)](/topic/$bpmc)

**Top topics mentioned**
In the posts about Prometheus Biosciences, Inc. Common Stock in the last XX hours

[gme](/topic/gme), [hong kong dollar](/topic/hong-kong-dollar), [spy](/topic/spy), [qqq](/topic/qqq), [gns](/topic/gns), [coins ai](/topic/coins-ai), [stocks](/topic/stocks), [$bbig](/topic/$bbig), [nasdaq](/topic/nasdaq), [fis](/topic/fis), [fmc](/topic/fmc), [tru](/topic/tru), [ibkr](/topic/ibkr), [$vtyx](/topic/$vtyx), [$tak](/topic/$tak), [$lly](/topic/$lly), [cere](/topic/cere), [teva](/topic/teva), [$cere](/topic/$cere), [$sobi](/topic/$sobi), [$ctlt](/topic/$ctlt), [investment](/topic/investment), [tars](/topic/tars), [surfing](/topic/surfing), [$vnda](/topic/$vnda), [$til](/topic/$til), [$tcrr](/topic/$tcrr), [$gevo](/topic/$gevo), [$bull](/topic/$bull), [$curr](/topic/$curr), [$btog](/topic/$btog), [blu](/topic/blu), [approved](/topic/approved), [$apgn](/topic/$apgn), [$vect](/topic/$vect), [$mgta](/topic/$mgta), [stockmarket](/topic/stockmarket), [$dbgi](/topic/$dbgi), [$dwac](/topic/$dwac), [$fwbi](/topic/$fwbi), [$sndl](/topic/$sndl), [$morf](/topic/$morf), [$jnj](/topic/$jnj), [$ibb](/topic/$ibb), [$xbi](/topic/$xbi), [$itci](/topic/$itci), [$bpmc](/topic/$bpmc)

### Top Social Posts [#](/topic/$rxdx/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"RSLS about to explode 💥 Merger vote next week patents stacking float microscopic this is the calm before the rocket 🚀🔥 #trading #stockmarket #crypto #technicalanalysis #tradingstrategy $PRST $CFRX $KWE $NRBO $RXDX $BBIG $GME $GEVO $IBIO $HKD $HUDI $ADTX $BGLC $DWAC $DBGI"  
[@FLOATRAIDER](/creator/x/FLOATRAIDER) on [X](/post/tweet/1946660258035712335) 2025-07-19 19:55:47 UTC XX followers, XXX engagements


"RSLS : Low float lots of revenues undervalued gem Strong uptrend forming + Vyome merger catalyst NEXT WEEK = recipe for a breakout. Holding tight 💪 #stocks #investing $PRST $CFRX $KWE $NRBO $RXDX $BBIG $GME $GEVO $IBIO $HKD $HUDI $ADTX $BGLC $DWAC $DBGI $SNDL $FWBI $GNS"  
[@FLOATRAIDER](/creator/x/FLOATRAIDER) on [X](/post/tweet/1946267474825019411) 2025-07-18 17:55:00 UTC XX followers, XXX engagements


"$AMD $KVUE $MRO $PRU $MPC $DE $IRM $SON $RXDX $DELL $PARA $IBKR $IRM $TRU $BMRRY $PBR $KVUE $FANG $DUK $JOBY $VNO $LDOS $FMC $GEN $FTI $FIS $ENB $EL $TD $INTU $SU $BMY $ADSK $TRIP $GM $APO $CPRT $TTD"  
[@linhnguyen64143](/creator/x/linhnguyen64143) on [X](/post/tweet/1945568743767044496) 2025-07-16 19:38:30 UTC XX followers, XXX engagements


"Citizens JMP reiterated $ABVX Mkt OP-$33 on its High-Conviction Catalysts Pick and said "Phase X ABTECT results for obefazimod in moderate-to-severe UC patients anticipated near term" $PTGX - $JNJ $MRK $LLY $TAK $VTYX Citizens added. "We reiterate our Market Outperform rating and risk-adjusted DCF derived $XX price target on Abivax. Abivax remains on track to report top-line results in 3Q25 from the Phase X induction trials evaluating obefazimod in moderate-to-severe ulcerative colitis. We remain confident in the potential for positive results in the Phase X trial driven by strong efficacy"  
[@Quantumup1](/creator/x/Quantumup1) on [X](/post/tweet/1944722511670726970) 2025-07-14 11:35:52 UTC 3523 followers, 5357 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Prometheus Biosciences, Inc. Common Stock Graphic Prometheus Biosciences, Inc. Common Stock (RXDX)

RXDX stock is buzzing with acquisition talks, with positive sentiment driving engagement. The stock price remains stable at $XXXXXX.

About Prometheus Biosciences, Inc. Common Stock

Prometheus Biosciences, Inc. Common Stock (RXDX) is a healthcare sector stock.
Prometheus Biosciences, Inc. Common Stock uses the ticker $RXDX for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

  • Prometheus Biosciences, Inc. Common Stock (RXDX) market dominance near a 52-week low at XXXXX.
  • Prometheus Biosciences, Inc. Common Stock (RXDX) galaxy score™ is up XX% from the previous month.
  • Prometheus Biosciences, Inc. Common Stock (RXDX) creators is up XXXXX% from the previous month.
  • Prometheus Biosciences, Inc. Common Stock (RXDX) engagements is up XXXXXX% from the previous week.

Price: $XXXXXX #

Price Line Chart
Price 24-Hour Chart Data
The stock price of $XXXXXX is likely supported by positive social sentiment regarding acquisition potential, despite the lack of recent price movement and being near its 52-week low.

1-Year High: $XXXXXX on 2024-07-21
1-Year Low: $XXXXXX on 2024-07-21

AltRank: XXXXX #

AltRank Line Chart
AltRank 24-Hour Chart Data
Prometheus Biosciences, Inc. Common Stock (RXDX) is currently AltRank #1,085 based on combined combined social and market metrics Daily Average: XXXXX
1 Week: XXXXX -XX
1 Month: XXXXX -XXX
6 Months: XXXXX +917
1 Year: XXXXX +42
1-Year High: XXXXX on 2025-06-26
1-Year Low: XX on 2024-12-07

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +12
1 Month: XX +16
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2025-05-24

Engagements: XXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXXX +137%
1 Month: XXXXXX -XX%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXX -XX%
1-Year High: XXXXXX on 2024-08-20
1-Year Low: X on 2024-09-02

Social Network X
Engagements XXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XX no change
1 Month: XX +35%
6 Months: XXX -XX%
1 Year: XXX -XX%
1-Year High: XXX on 2024-11-24
1-Year Low: X on 2025-05-10

Social Network X
Mentions XX

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Prometheus Biosciences, Inc. Common Stock (RXDX) in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: X
1 Week: XX +13%
1 Month: XX +76%
6 Months: XX -XX%
1 Year: XXX +3.70%
1-Year High: XX on 2024-10-22
1-Year Low: X on 2025-05-10

The most influential creators that mention Prometheus Biosciences, Inc. Common Stock in the last XX hours

Creator Rank Followers Posts Engagements
@Quantumup1 X XXXXX X XXXXX

View More

Sentiment: XXX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% +50%
6 Months: XXX% no change
1 Year: XXX% no change
1-Year High: XXX% on 2024-07-22
1-Year Low: XX% on 2025-02-12

Most Supportive Themes

  • Acquisition Potential: (80%) The strategic value of RXDX and other biotech stocks is highlighted, indicating positive sentiment towards potential acquisitions and growth.

Most Critical Themes

  • Overpayment Concerns: (20%) Concerns about overpayment for RXDX in acquisitions.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XX X% XXX XX% X X%
Total XX X% XXX XX% X X%

Social Dominance: XXXXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
1 Week: XXXXXXX% -XXXXXXXXXXXXXXXXXXXXX%
1 Month: XXXXX% +0.0075%
6 Months: XXXXX% +0.0083%
1 Year: XXXXX% +0.0088%
1-Year High: XXXXX% on 2024-11-24
1-Year Low: XXXXXX% on 2025-05-10

Market Dominance: XXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-05-19
1-Year Low: XXXXX% on 2025-07-17

Market Cap: $XXXXXXXXXXXXX #

Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Month: $XXXXXXXXXXXXX no change
1-Year High: $XXXXXXXXXXXXX on 2025-05-18
1-Year Low: $XXXXXXXXXXXXX on 2025-05-18

Top assets mentioned In the posts about Prometheus Biosciences, Inc. Common Stock in the last XX hours

Eli Lilly and Company (LLY) Cere Network (CERE) Catalent Inc (CTLT) Bull Market (BULL) Johnson & Johnson (JNJ) Bitcoin Incognito (XBI) Intra-Cellular Therapies Inc. (ITCI) Blueprint Medicines Corporation (BPMC)

Top topics mentioned In the posts about Prometheus Biosciences, Inc. Common Stock in the last XX hours

gme, hong kong dollar, spy, qqq, gns, coins ai, stocks, $bbig, nasdaq, fis, fmc, tru, ibkr, $vtyx, $tak, $lly, cere, teva, $cere, $sobi, $ctlt, investment, tars, surfing, $vnda, $til, $tcrr, $gevo, $bull, $curr, $btog, blu, approved, $apgn, $vect, $mgta, stockmarket, $dbgi, $dwac, $fwbi, $sndl, $morf, $jnj, $ibb, $xbi, $itci, $bpmc

Top Social Posts #

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"RSLS about to explode 💥 Merger vote next week patents stacking float microscopic this is the calm before the rocket 🚀🔥 #trading #stockmarket #crypto #technicalanalysis #tradingstrategy $PRST $CFRX $KWE $NRBO $RXDX $BBIG $GME $GEVO $IBIO $HKD $HUDI $ADTX $BGLC $DWAC $DBGI"
@FLOATRAIDER on X 2025-07-19 19:55:47 UTC XX followers, XXX engagements

"RSLS : Low float lots of revenues undervalued gem Strong uptrend forming + Vyome merger catalyst NEXT WEEK = recipe for a breakout. Holding tight 💪 #stocks #investing $PRST $CFRX $KWE $NRBO $RXDX $BBIG $GME $GEVO $IBIO $HKD $HUDI $ADTX $BGLC $DWAC $DBGI $SNDL $FWBI $GNS"
@FLOATRAIDER on X 2025-07-18 17:55:00 UTC XX followers, XXX engagements

"$AMD $KVUE $MRO $PRU $MPC $DE $IRM $SON $RXDX $DELL $PARA $IBKR $IRM $TRU $BMRRY $PBR $KVUE $FANG $DUK $JOBY $VNO $LDOS $FMC $GEN $FTI $FIS $ENB $EL $TD $INTU $SU $BMY $ADSK $TRIP $GM $APO $CPRT $TTD"
@linhnguyen64143 on X 2025-07-16 19:38:30 UTC XX followers, XXX engagements

"Citizens JMP reiterated $ABVX Mkt OP-$33 on its High-Conviction Catalysts Pick and said "Phase X ABTECT results for obefazimod in moderate-to-severe UC patients anticipated near term" $PTGX - $JNJ $MRK $LLY $TAK $VTYX Citizens added. "We reiterate our Market Outperform rating and risk-adjusted DCF derived $XX price target on Abivax. Abivax remains on track to report top-line results in 3Q25 from the Phase X induction trials evaluating obefazimod in moderate-to-severe ulcerative colitis. We remain confident in the potential for positive results in the Phase X trial driven by strong efficacy"
@Quantumup1 on X 2025-07-14 11:35:52 UTC 3523 followers, 5357 engagements

Prometheus Biosciences, Inc. Common Stock (RXDX)
/topic/$rxdx